Asian Penny Stocks With Market Caps Under US$13B

Amidst a backdrop of global economic challenges and shifting trade dynamics, Asian markets have been navigating a complex landscape. For investors considering alternatives to the major indices, penny stocks—often representing smaller or newer companies—remain an intriguing option. While the term "penny stock" might seem outdated, these investments can still offer substantial opportunities when backed by strong financial health and potential for growth.

Top 10 Penny Stocks In Asia

Name	Share Price	Market Cap	Rewards & Risks
YKGI (Catalist:YK9)	SGD0.153	SGD64.42M	✅ 2 ⚠️ 4 View Analysis >
Lever Style (SEHK:1346)	HK$1.42	HK$878.3M	✅ 4 ⚠️ 1 View Analysis >
Asia Medical and Agricultural Laboratory and Research Center (SET:AMARC)	THB2.62	THB1.1B	✅ 3 ⚠️ 3 View Analysis >
TK Group (Holdings) (SEHK:2283)	HK$2.45	HK$2.03B	✅ 4 ⚠️ 1 View Analysis >
Atlantic Navigation Holdings (Singapore) (Catalist:5UL)	SGD0.132	SGD69.1M	✅ 2 ⚠️ 3 View Analysis >
Yangzijiang Shipbuilding (Holdings) (SGX:BS6)	SGD3.31	SGD13.03B	✅ 5 ⚠️ 1 View Analysis >
Anton Oilfield Services Group (SEHK:3337)	HK$1.05	HK$2.78B	✅ 3 ⚠️ 2 View Analysis >
NagaCorp (SEHK:3918)	HK$4.35	HK$19.24B	✅ 5 ⚠️ 1 View Analysis >
Livestock Improvement (NZSE:LIC)	NZ$1.00	NZ$142.34M	✅ 2 ⚠️ 3 View Analysis >
Scott Technology (NZSE:SCT)	NZ$2.90	NZ$243.88M	✅ 4 ⚠️ 0 View Analysis >

Click here to see the full list of 944 stocks from our Asian Penny Stocks screener.

Underneath we present a selection of stocks filtered out by our screen.

China Shengmu Organic Milk (SEHK:1432)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: China Shengmu Organic Milk Limited is an investment holding company involved in the production and distribution of raw milk and dairy products in China, with a market cap of HK$3.22 billion.

Operations: The company generates revenue primarily from its Dairy Farming Business, which accounted for CN¥3.08 billion.

Market Cap: HK$3.22B

China Shengmu Organic Milk Limited, with a market cap of HK$3.22 billion, has recently become profitable despite a 41.9% annual decline in earnings over the past five years. The company's net debt to equity ratio is satisfactory at 30.5%, and interest payments are well-covered by EBIT, indicating financial stability. However, short-term liabilities exceed short-term assets by CN¥900 million, posing potential liquidity concerns. A significant development includes China Modern Dairy Holdings' proposal to acquire an additional stake in the company for HK$2 billion, which could impact its strategic direction and shareholder value significantly if completed successfully.

• Unlock comprehensive insights into our analysis of China Shengmu Organic Milk stock in this financial health report.
• Review our historical performance report to gain insights into China Shengmu Organic Milk's track record.

SenseTime Group (SEHK:20)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: SenseTime Group Inc. is an investment holding company that researches, develops, and sells artificial intelligence software platforms across Mainland China, Northeast Asia, Southeast Asia, and internationally with a market cap of HK$99.44 billion.

Operations: The company generates revenue primarily from its Software & Programming segment, amounting to CN¥4.39 billion.

Market Cap: HK$99.44B

SenseTime Group Inc., with a market cap of HK$99.44 billion, has recently completed a follow-on equity offering raising HK$3.15 billion, which may bolster its cash runway for over three years despite ongoing unprofitability. The company has shown revenue growth in its Software & Programming segment, generating CN¥4.39 billion, and is forecast to grow revenue by 23.96% annually. While it remains unprofitable with negative return on equity at -14.77%, SenseTime's financial position is supported by short-term assets exceeding both short and long-term liabilities significantly, indicating potential stability amidst volatility in the penny stock landscape.

• Navigate through the intricacies of SenseTime Group with our comprehensive balance sheet health report here.
• Explore SenseTime Group's analyst forecasts in our growth report.

Danhua Chemical TechnologyLtd (SHSE:600844)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Danhua Chemical Technology Co., Ltd, along with its subsidiaries, is involved in the production and sale of coal chemical products in China and has a market capitalization of CN¥2.88 billion.

Operations: The company generates CN¥870.66 million in revenue from its chemical industry segment.

Market Cap: CN¥2.88B

Danhua Chemical Technology Co., Ltd, with a market cap of CN¥2.88 billion, reported nine-month revenue of CN¥687.59 million, an increase from the previous year, though it remains unprofitable with a net loss of CN¥88.8 million. The company has more cash than debt and sufficient cash runway for over three years if free cash flow declines at historical rates. However, its short-term liabilities exceed short-term assets significantly, posing liquidity challenges despite stable weekly volatility and no recent shareholder dilution. The management team is experienced but the board lacks tenure depth, indicating potential governance shifts in this penny stock environment.

• Click here and access our complete financial health analysis report to understand the dynamics of Danhua Chemical TechnologyLtd.
• Gain insights into Danhua Chemical TechnologyLtd's historical outcomes by reviewing our past performance report.

Make It Happen

• Unlock more gems! Our Asian Penny Stocks screener has unearthed 941 more companies for you to explore.Click here to unveil our expertly curated list of 944 Asian Penny Stocks.
• Contemplating Other Strategies? AI is about to change healthcare. These 109 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com